0000885590-13-000021.txt : 20130423 0000885590-13-000021.hdr.sgml : 20130423 20130423142349 ACCESSION NUMBER: 0000885590-13-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130420 FILED AS OF DATE: 20130423 DATE AS OF CHANGE: 20130423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kornwasser Laizer CENTRAL INDEX KEY: 0001387813 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 13776068 MAIL ADDRESS: STREET 1: 100 PARSONS POND DRIVE CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-04-20 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001387813 Kornwasser Laizer 4787 LEVY ROAD MONTREAL A8 H4R 2P9 QUEBEC, CANADA 0 1 0 0 EVP, Company Group Chairman Common Stock, no par value 2013-04-20 4 A 0 2000 0 A 4000 D Represents Restricted Share Units received under an Employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. 1/3 of the Matching RSUs will vest each on the first, second and third anniversary of the date of grant subject to continued employment and retention of the corresponding purchased shares. This number represents common shares purchased by the officer, as well as other outstanding equity awards that were previously reported in Table 1. by: Nicholas Zanoni for Laizer Kornwasser 2013-04-23